CEL-SCI CORP
CEL-SCI CORP
Share · US1508376076 · CVM · A2DY0D (XASE)
Overview Financial Indicators
8,91 USD
-4,57 % -0,43 USD
AMEX (XNYS) · Current prices and charts at MoneyPeak
04.08.2025 21:39

Current Prices from CEL-SCI CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
CVM
USD
04.08.2025 21:39
8,91 USD
-0,54 USD
-5,68 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 24,83 % 257,94 % 18,18 % 2.205,43 % 688,74 % -97,53 %

Company Profile for CEL-SCI CORP Share

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Company Data

Name CEL-SCI CORP
Company CEL-SCI Corporation
Symbol CVM
Website https://cel-sci.com
Primary Exchange XASE AMEX
WKN A2DY0D
ISIN US1508376076
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Geert R. Kersten Esq.
Market Capitalization 13 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 8229 Boone Boulevard, 22182 Vienna
IPO Date 1983-12-08
Dividends from 'CEL-SCI CORP'
Ex-Date Dividend per Share
28.08.1996 0,25 USD

Stock Splits

Date Split
20.05.2025 1:30
15.06.2017 1:25
25.09.2013 1:10
01.05.1995 1:10

Ticker Symbols

Name Symbol
Frankfurt LSRM.F
NYSE CVM

More Shares

Investors who hold CEL-SCI CORP also have the following shares in their portfolio:
ALTICE FIN. 20/28 REGS
ALTICE FIN. 20/28 REGS Bond
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
CITY OF GOTEBORG 0.633% NTS 16/03/22
CITY OF GOTEBORG 0.633% NTS 16/03/22 Bond
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EBAY INC
EBAY INC Share
FIRST TRUST NASDAQ ABA COMMUNITY BANK INDEX FUND
FIRST TRUST NASDAQ ABA COMMUNITY BANK INDEX FUND ETF
INTEL CORP
INTEL CORP Share
LGT-LGT SUS.EQ.EUROPE B
LGT-LGT SUS.EQ.EUROPE B Fund
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025